167 related articles for article (PubMed ID: 37225922)
1. Targeting multi-drug-resistant Acinetobacter baumannii: a structure-based approach to identify the promising lead candidates against glutamate racemase.
Kumar A; Singh E; Jha RK; Khan RJ; Jain M; Varshney S; Muthukumaran J; Singh AK
J Mol Model; 2023 May; 29(6):188. PubMed ID: 37225922
[TBL] [Abstract][Full Text] [Related]
2. Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis.
Jha RK; Khan RJ; Amera GM; Singh E; Pathak A; Jain M; Muthukumaran J; Singh AK
J Mol Model; 2020 Oct; 26(11):304. PubMed ID: 33068184
[TBL] [Abstract][Full Text] [Related]
3. An extensive computational study to identify potential inhibitors of Acyl-homoserine-lactone synthase from Acinetobacter baumannii (strain AYE).
Jha RK; Jabeer Khan R; Singh E; Kumar A; Jain M; Muthukumaran J; Singh AK
J Mol Graph Model; 2022 Jul; 114():108168. PubMed ID: 35339024
[TBL] [Abstract][Full Text] [Related]
4. Droperidol as a potential inhibitor of acyl-homoserine lactone synthase from A. baumannii: insights from virtual screening, MD simulations and MM/PBSA calculations.
Jha RK; Singh E; Khan RJ; Kumar A; Jain M; Muthukumaran J; Singh AK
Mol Divers; 2023 Oct; 27(5):1979-1999. PubMed ID: 36190592
[TBL] [Abstract][Full Text] [Related]
5. Structure based drug designing and discovery of promising lead molecules against UDP-N-acetylenolpyruvoylglucosamine reductase (MurB): A potential drug target in multi-drug resistant Acinetobacter baumannii.
Amera GM; Khan RJ; Pathak A; Jha RK; Jain M; Muthukumaran J; Singh AK
J Mol Graph Model; 2020 Nov; 100():107675. PubMed ID: 32731183
[TBL] [Abstract][Full Text] [Related]
6. A computational perspective towards the identification of promising lead molecules against 6-hydroxy-methyl dihydropterin pyrophosphokinase (HPPK) from
Bhati SK; Jain M; Muthukumaran J; Singh AK
J Biomol Struct Dyn; 2023 Jul; ():1-10. PubMed ID: 37490027
[No Abstract] [Full Text] [Related]
7. Computer aided ligand based screening for identification of promising molecules against enzymes involved in peptidoglycan biosynthetic pathway from Acinetobacter baumannii.
Amera GM; Khan RJ; Pathak A; Jha RK; Muthukumaran J; Singh AK
Microb Pathog; 2020 Oct; 147():104205. PubMed ID: 32353580
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional characterization of 1-deoxy-D-xylulose-5-phosphate synthase (DXS) from
Parveez Zia M; Singh E; Jain M; Muthukumaran J; Singh AK
J Biomol Struct Dyn; 2023; 41(21):11598-11611. PubMed ID: 36752319
[TBL] [Abstract][Full Text] [Related]
9. Screening of promising molecules against MurG as drug target in multi-drug-resistant-
Amera GM; Khan RJ; Pathak A; Jha RK; Muthukumaran J; Singh AK
J Biomol Struct Dyn; 2020 Oct; 38(17):5230-5252. PubMed ID: 31787065
[TBL] [Abstract][Full Text] [Related]
10. Exploration of potential hit compounds targeting 1-deoxy-d-xylulose 5-phosphate reductoisomerase (IspC) from
Zia MP; Jain M; Muthukumaran J; Singh AK
3 Biotech; 2024 Mar; 14(3):72. PubMed ID: 38362590
[TBL] [Abstract][Full Text] [Related]
11. Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii - insights from molecular docking, molecular dynamic simulations and in vitro assays.
Skariyachan S; Manjunath M; Bachappanavar N
J Biomol Struct Dyn; 2019 Mar; 37(5):1146-1169. PubMed ID: 29529934
[TBL] [Abstract][Full Text] [Related]
12.
Liechti G; Singh R; Rossi PL; Gray MD; Adams NE; Maurelli AT
mBio; 2018 Apr; 9(2):. PubMed ID: 29615498
[TBL] [Abstract][Full Text] [Related]
13. Carboxymuconolactone decarboxylase is a prospective molecular target for multi-drug resistant Acinetobacter baumannii-computational modeling, molecular docking and dynamic simulation studies.
Rana S; Skariyachan S; Uttarkar A; Niranjan V
Comput Biol Med; 2023 May; 157():106793. PubMed ID: 36944292
[TBL] [Abstract][Full Text] [Related]
14. Identification and prioritization of potential therapeutic molecules against LpxA from
Khan RJ; Singh E; Jha RK; Kumar A; Bhati SK; Zia MP; Jain M; Singh RP; Muthukumaran J; Singh AK
Curr Res Struct Biol; 2023; 5():100096. PubMed ID: 36895415
[TBL] [Abstract][Full Text] [Related]
15. Revisiting the essentiality of glutamate racemase in Mycobacterium tuberculosis.
Morayya S; Awasthy D; Yadav R; Ambady A; Sharma U
Gene; 2015 Jan; 555(2):269-76. PubMed ID: 25447907
[TBL] [Abstract][Full Text] [Related]
16. Comparative subtractive proteomics based ranking for antibiotic targets against the dirtiest superbug: Acinetobacter baumannii.
Ahmad S; Raza S; Uddin R; Azam SS
J Mol Graph Model; 2018 Jun; 82():74-92. PubMed ID: 29705560
[TBL] [Abstract][Full Text] [Related]
17. The glutamate racemase activity from Escherichia coli is regulated by peptidoglycan precursor UDP-N-acetylmuramoyl-L-alanine.
Doublet P; van Heijenoort J; Mengin-Lecreulx D
Biochemistry; 1994 May; 33(17):5285-90. PubMed ID: 8172902
[TBL] [Abstract][Full Text] [Related]
18. The murI gene of Escherichia coli is an essential gene that encodes a glutamate racemase activity.
Doublet P; van Heijenoort J; Bohin JP; Mengin-Lecreulx D
J Bacteriol; 1993 May; 175(10):2970-9. PubMed ID: 8098327
[TBL] [Abstract][Full Text] [Related]
19. Ethambutol targets the glutamate racemase of Mycobacterium tuberculosis-an enzyme involved in peptidoglycan biosynthesis.
Pawar A; Jha P; Konwar C; Chaudhry U; Chopra M; Saluja D
Appl Microbiol Biotechnol; 2019 Jan; 103(2):843-851. PubMed ID: 30456576
[TBL] [Abstract][Full Text] [Related]
20. Exploring the structure of glutamate racemase from Mycobacterium tuberculosis as a template for anti-mycobacterial drug discovery.
Poen S; Nakatani Y; Opel-Reading HK; Lassé M; Dobson RC; Krause KL
Biochem J; 2016 May; 473(9):1267-80. PubMed ID: 26964898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
